Hereditary Breast & Ovarian Cancer: When to Ask for BRCA Testing in India
When to ask for BRCA testing in India — eligibility, cost, what the result means for you and your family. Dr. Nishtha Tripathi Patel, ESGO-certified.
Expert articles on gynaecological cancers, surgical treatments and women's health — written by Dr. Nishtha Tripathi Patel, ESGO-certified Gynaecological Oncosurgeon, Ahmedabad.
When to ask for BRCA testing in India — eligibility, cost, what the result means for you and your family. Dr. Nishtha Tripathi Patel, ESGO-certified.
Most ovary lumps in young women are harmless. Borderline and germ-cell tumours are less common, very treatable, and fertility can often be kept.
A plain guide to genetic testing for inherited ovarian, womb and breast cancer: who should be tested, what BRCA and Lynch results mean, and the next steps for your family.
What the CA-125 blood test measures, what the normal range means, why it can be high without cancer, and when a raised level should be seen by a specialist.
When immunotherapy may help ovarian cancer, which tests matter, and what the latest pembrolizumab, FIRST and DUO-O evidence means for patients.
What the DUO-O trial found about durvalumab, bevacizumab and olaparib for advanced ovarian cancer without a tumour BRCA mutation.
What happens after one ovary is removed? Understand periods, hormones, fertility, pregnancy, menopause timing, long-term health and monitoring of the remaining ovary.
Understand PARP inhibitor maintenance after ovarian cancer treatment, including BRCA and HRD results, olaparib, niraparib, fuzuloparib evidence, side effects and monitoring.
Stage I ovarian clear-cell cancer does not always have one chemotherapy answer. Understand IA and IC substages, complete staging, recurrence evidence and fertility considerations.
HIPEC and conventional intraperitoneal chemotherapy both treat the abdomen but differ in heat, timing and schedule. Understand the evidence, risks and treatment decisions.
Need guidance on the next step in care?